The authors concluded that both subcutaneous and oral insulin administration did not prevent or delay T1D onset [21], although in a subgroup with anti-insulin autoantibodies persistently at high levels (> 80 nU/mL), a delay in the diagnosis of diabetes (as compared to the placebo group) has been demonstrated (Table 1). This evidence concerns the gene INS and type 1 diabetes mellitus.